Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin-4 receptor alpha subunit (IL-4Rα, also known as CD124) is a type I transmembrane protein that serves as the principal binding component for interleukin-4 (IL-4) and interleukin-13 (IL-13). It is ubiquitously expressed on both innate and adaptive immune cells and plays a crucial role in regulating humoral immunity and promoting Th2-type immune responses. Dysregulation of IL-4Rα is linked to atopic diseases.
Inhibition of IL-4 and IL-13 signaling by blocking IL-4Rα.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-4 Receptor Alpha Subunit (IL-4Rα).